News Briefing channel feed – Endpoints News

News Briefing channel feed

On a shopping spree, Allergan bags CoolSculpting tech in $2.5B buyout; Akebia strikes research deal with J&J

9 years ago

Tracon shares slammed by PhII bust in brain cancer study; Visterra yanks its IPO in back-to-back duds

9 years ago

Tetraphase CEO touts troubled antibiotic’s peak sales potential; Copenhagen wants to host the EMA

9 years ago

Lysogene raises $25M in Paris IPO; Chan Zuckerberg Biohub starts handing out $50M

9 years ago

GW touts positive survival benefit in small brain cancer study; Ablynx files for ultra-rare disease drug OK

9 years ago

Chondrial bags a $22M A round for mitochondrial R&D; Ariad filed marketing app for brigatinib

9 years ago

Stemline comes clean on patient death, but questions linger; Life sciences fund launches with €100M

9 years ago

J&J makes new investments in microbiome R&D; UK’s Arix out to raise £100 million for new biotech investments

9 years ago

Canada hands Sanofi, Regeneron their first OK for sarilumab; Rigel raises $40 million

9 years ago

Pfizer prunes three drugs from its pipeline; Astellas in-licenses ear drug

9 years ago

uniQure wins a BTD for hemophilia B therapy; Allergan scores sNDA for Avycaz

9 years ago

Novartis silently yanks a troubled biosimilar application; Chinese antibody developer draws $39M round

9 years ago

Endo axes R&D staff in restructuring; China biotech Connect raises $20 million

9 years ago

Zymeworks adds a new lab for fast-growing R&D work; Novartis considers a spinoff for Alcon

9 years ago

Regeneron buys its HQ site for $720M; Fast-growing Seattle Genetics plans 200 more hires this year

9 years ago

Bizarre takeover bid is dropped; Merck KGaA in licensing pact with Domain

9 years ago

Pfizer signs up for match-making service; Investors tell Sanofi: Make a deal, now

9 years ago

Cytori bags Azaya drugs in asset purchase; Woodford offers a mea culpa on Northwest Bio

9 years ago

Merrimack recruits Sanofi vet Richard Peters for the top job; ObsEva and Braeburn detail their IPO shots

9 years ago

Upstart maps plans to build fibrosis pipeline; FDA extends review period for Lilly’s baricitinib

9 years ago

OncoImmune raises $15M for PhII GvHD study; FDA wraps biosimilar naming guidance

9 years ago

Biogen spinoff begins trading today; New oncology chief at AstraZeneca

9 years ago

Eli Lilly, Merck add new combo alliance; Gilead really does want to focus on M&A

9 years ago

Valeant auctions off Dendreon, skincare assets; Bayer to collaborate with the University of Pittsburgh

9 years ago

First page Previous page 72 73 747576 77 78 Next page Last page